Burgess iridium(I)-catalyst for selective hydrogen isotope exchange

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 60, Issue 7, 2017, Pages 343-348

  Burhop, Annina ^a   Prohaska, Raphail ^a   Weck, Remo ^a   Atzrodt, Jens ^a   Derdau, Volker ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Burgess catalyst; CH activation; deuterium; hydrogen isotope exchange

Indexed keywords

ALDEHYDE; CARBOXYLIC ACID; DEUTERIUM; FLUOROBENZENE; HYDROGEN; IMIDAZOLE; IRIDIUM; KETONE; OXAZOLE; PYRAZINE; PYRIDINE;

ARTICLE; CATALYSIS; CATALYST; DEUTERIUM HYDROGEN EXCHANGE; HYDROGENATION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; REACTION ANALYSIS; REACTION TIME; ROOM TEMPERATURE; CHEMISTRY;

CATALYSIS; DEUTERIUM; IRIDIUM;

EID: 85019179597     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.3512     Document Type: Article

References (56)

1. For selected reviews, see: a)Atzrodt J, Derdau V, Fey T, Zimmermann J. Angew Chem Int Ed. 2007;46:7744-7765;
2. Modutlwa N, Maegawa T, Monguchi Y, Sajiki H. J Label Compd Radiopharm. 2010;53:686-692;
3. Atzrodt J, Derdau V. J Label Compd Radiopharm. 2010;53:674-685;
4. Heys JR. Label Compd Radiopharm. 2010;53:716-721;
5. Lockley WJS, Heys JR. J Label Compd Radiopharm. 2010;53:635-644;
6. Lockley WJS, Hesk D. J Label Compd Radiopharm. 2010;53:704-715;
7. Sawama Y, Monguchi Y, Sajiki H. Synlett. 2012;23:959-972;
8. Di Guiseppe A, Castarlenas R, Oro LA. C R Chim. 2015;18:713-741.
9. For recent selected examples, see: a)Hatano M, Nishimura T, Yorimitsu H. Org Lett. 2016;18(15):3674-3677;
10. Taglang C, Martinez-Prieto LM, del Rosal I, et al. Angew Chem Int Ed. 2015;54:10474-10477;
11. Bai W, Lee KH, Tse SKS, Chan KW, Lin Z, Jia G. Organometallics. 2015;34:3686-3698;
12. Ma S, Villa G, Thuy-Boun PS, Homs A, Yu J-Q. Angew Chem Int Ed. 2014;53:734-737;
13. Pieters G, Taglang C, Bonnefille E, et al. Angew Chem Int Ed. 2014;53:230-234;
14. Neubert L, Michalik D, Bähn S, et al. J Am Chem Soc. 2012;134(29):2239-12244;
15. Atzrodt J, Blankenstein J, Brasseur D, et al. Bioorg Med Chem. 2012;20(18):5658-5667;
16. Gröll B, Schnürch M, Mihovilovic MD. J Org Chem. 2012;77:4432-4437;
17. Zhou J, Hartwig JF. Angew Chem Int Ed. 2008;47:5783-5787.
18. For recent selected examples, see: a)Yu RP, Hesk D, Rivera N, Pelczer I, Chirik PJ. Nature. 2016;529:195-199;
19. Kang J, Vonderheide A, Guliants VV. ChemSusChem. 2015;8:3044-3047;
20. Shevchenko VP, Badun GA, Razzhivina IA, Nagaev IY, Shevchenko KV, Myasoedov NF. Dokl Phys Chem. 2015;463:182-187;
21. Pollack SR, Schenk DJ. J Label Compd Radiopharm. 2015;58:433-441.
22. Lockley WJS, McEwen A, Cooke R. J Label Compd Radiopharm. 2012;55:235-257;
23. Elmore CS, Bragg RA. Bioorg Med Chem Lett. 2015;25:167-171;
24. Uhl P, Fricker G, Haberkorn U, Mier W. Drug Disc Today. 2015;20(2):198-208;
25. Saljoughian M, Williams PG. Curr Pharm Des. 2000;6:1029-1056.
26. For selected reviews, see: a)Salter R. J Label Compd Radiopharm. 2010;53:645-657;
27. Herbert JM. J Label Compd Radiopharm. 2010;53:658-661;
28. Nilsson G, Kerr WJ. J Label Compd Radiopharm. 2010;53:662-667;
29. Lockley WJS. J Label Compd Radiopharm. 2010;53:668-673.
30. Crabtree R. Acc Chem Res. 1979;12:331-337.
31. Hesk D, Das PR, Evans B. J Label Compd Radiopharm. 1995;36:497-502.
32. Atzrodt J, Derdau V, Kerr WJ, Reid M, Rojahn P, Weck R. Tetrahedron. 2015;71:1924-1929;
33. Simonsson R, Stenhagen G, Ericsson C, Elmore CS. J Label Compd Radiopharm. 2013;56:334-337;
34. Filer CN. J Label Compd Radiopharm. 2010;53:739-744;
35. Chappelle M, Hawes CR. J Label Compd Radiopharm. 2010;53:745-751.
36. Voges R, Heys R, Moenius T. Preparation of Compounds labeled with Tritium and Carbon-14. Chichester, UK: Wiley; 2009.
37. Kerr WJ, Lindsay DM, Reid M, et al. Chem Commun. 2016;52:6669-6672;
38. Cross PWC, Herbert JM, Kerr WJ, McNeill AH, Paterson LC. Synlett. 2016;27:111-115;
39. Devlin J, Kerr WJ, Lindsay DM, McCabe TJD, Reid M, Tuttle T. Molecules. 2015;20:11676-11698;
40. Brown JA, Cochrane AR, Irvine S, et al. Adv Synth Catal. 2014;356:3551-3562;
41. Cochrane AR, Irvine S, Kerr WJ, Reid M, Andersson S, Nilsson GN. J Label Compd Radiopharm. 2013;56:451-454.
42. Parmentier M, Hartung T, Pfaltz A, Muri D. Chem A Eur J. 2014;20:11496-11504.
43. Jess K, Derdau V, Weck R, et al. Adv. Synth. Catal. 2017;359:629-638.
44. Powell MT, Hou D-R, Perry MC, Cui X, Burgess K. J Am Chem Soc. 2001;123:8878-8879;
45. Perry MC, Cui X, Powell MT, Hou DR, Reibenspies JH, Burgess K. J Am Chem Soc. 2003;125:113-123.
46. Khumsubdee S, Fan Y, Burgess K. J Org Chem. 2013;9969-9974;
47. Zhu Y, Fan Y, Burgess K. J Am Chem Soc. 2010;132:6249-6253.
48. Burhop A, Weck R, Atzrodt J, Derdau V. Eur J Org Chem. 2017;1418-1424.
49. Kerr WJ, Reid M, Tuttle T. ACS Catal. 2015;5:402-410.
50. Lockley WJS. J Label Compd Radiopharm. 2010;53:668-673 and references therein.
51. We propose that 2-MeTHF coordinates to the iridium catalyst in competition to the substrate. In comparison to MTBE the coordination seems to be much stronger as demonstrated by deuterium introduction of <20% with model compounds 7,8 and 9.
52. The transition state seems to work only in a five membered ring iridium-arene complex (for the peri position) and not via a four-membered ring necessary to exchange the hydrogen in the 2-position of 1-naphthylamine 9.
53. A faster and more efficient deuterium exchange was observed in the kinetic study as compared to the screening results in table 2 under similar conditions (entry 3 after 2 h). The reason for this small discrepancy may be a different experimental set-up with Heidolph parallel Synthesizer (with shacking) utilized for all screening reactions in contrast to the kinetic studies performed in a 50 mL flask with stirring.
54. We did not observe deuterium pressure dependency in any of our performed iridium-catalyzed HIE reactions.
55. Brown JA, Irvine S, Kennedy AR, Kerr WJ, Andersson S, Nilsson GN. Chem Commun. 2008;1115-1117;
56. Cochrane AR, Idziak C, Kerr WJ, et al. Org Biomol Chem. 2014;12:3598-3603.